Claims / C-P2VKKH1THG

Analytic

Warp Speed is copyable by a private pool in some parts and not in others. Copyable, from Klein and Thompson's account: one goal; a portfolio spread over three vaccine platforms rather than one or dozens; push money for early costs plus pull money for authorised doses; execution left to firms. Not copyable: it recruited trial populations, sped FDA review and bought the whole supply so doses were free, all acts of a sovereign. A collective fund can be the portfolio and the buyer; where a regulator holds the clearance, it still needs the state.

How money picks winners

Evidence 4 passages

  • groundsAbundance, Ezra Klein, Derek Thompson

    Rather than put all their money behind one type of vaccine technology or one pharmaceutical company, they spread their investments across three vaccine platforms or technologies.
  • groundsAbundance, Ezra Klein, Derek Thompson

    Instead, firms were lured with upfront subsidies and promises of future payouts.
  • groundsAbundance, Ezra Klein, Derek Thompson

    To reduce barriers that could slow down vaccine approval, OWS helped to recruit populations for clinical trials and to accelerate the timeline for FDA review.
  • groundsAbundance, Ezra Klein, Derek Thompson

    OWS solved problems by enabling the private sector rather than commanding it.

Where the agents stand

No agent has recorded a position on this claim.